{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T21:03:31Z","timestamp":1784063011349,"version":"3.55.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Brandenburg CAMPUS GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute kidney injury (AKI) is a common and serious complication of hospitalized patients worldwide. In most cases, the syndrome is characterized by dysfunction\/structural damage of the tubular epithelial cells. The metabolic feature is a reduction in cellular adenosine triphosphate (ATP) synthesis as a result of decreased fatty acid oxidation. Stabilization of the fatty acid (FA) oxidation process may influence the course of AKI, whether caused by endogenous or exogenous factors. In this narrative review, we discuss experimental evidence on the modulation of fatty acid metabolism in AKI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Narrative review article. The following databases were searched for references: PubMed, Web of Science, Cochrane Library, Scopus. The period lasted from 2010 until May 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Finally, 16 articles on the modulation of fatty acid metabolism in experimental AKI were identified. Disturbances in the FA oxidation process are associated with an aggravation of renal dysfunction in AKI, and lipids accumulate in the renal tissue itself. The consequences of exogenous fatty acid intake depend on the structural characteristics of the metabolites applied, as well as on the pattern of renal damage and the relevant pathophysiological processes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Under certain conditions, adequate fatty acid oxidation may be considered nephroprotective; however, the complexity of the syndrome\u2019s pathophysiology must always be taken into account. Distinct fatty acids have the potential to offer therapeutic benefits in AKI cases. However, the efficacy of an FA-based therapeutic approach depends on two main factors: the chemical structure of the substances used and the nature of the underlying kidney disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-026-05166-8","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:05:18Z","timestamp":1783937118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impaired fatty acid metabolism in AKI: experimental evidence \u2013 a narrative review"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4221-9022","authenticated-orcid":false,"given":"Johanna","family":"Gruzla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8892-1805","authenticated-orcid":false,"given":"Stefan","family":"Erfurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6234-5229","authenticated-orcid":false,"given":"Benedikt","family":"Marahrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5361-4327","authenticated-orcid":false,"given":"Karsten-Henrich","family":"Weylandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-4364","authenticated-orcid":false,"given":"Oliver","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6914-5254","authenticated-orcid":false,"given":"Daniel","family":"Patschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"9","key":"5166_CR1","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.2215\/CJN.00710113","volume":"8","author":"P Susantitaphong","year":"2013","unstructured":"Susantitaphong P, Cruz DN, Cerda J, Abulfaraj M, Alqahtani F, Koulouridis I, et al. World Incidence of AKI: A Meta-Analysis. Clin J Am Soc Nephrol. 2013;8(9):1482\u201393. https:\/\/doi.org\/10.2215\/CJN.00710113.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"5166_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","volume":"14","author":"EAJ Hoste","year":"2018","unstructured":"Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol. 2018;14(10):607\u201325. https:\/\/doi.org\/10.1038\/s41581-018-0052-0. PubMed PMID: 30135570.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"5166_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/jcm12010375","volume":"12","author":"F Turgut","year":"2023","unstructured":"Turgut F, Awad AS, Abdel-Rahman EM. Acute Kidney Injury: Medical Causes and Pathogenesis. J Clin Med. 2023;12(1):375. https:\/\/doi.org\/10.3390\/jcm12010375PubMed.\u00a0PMID: 36615175; PubMed Central PMCID: PMC9821234.","journal-title":"J Clin Med"},{"issue":"7","key":"5166_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jacc.2008.05.068","volume":"53","author":"W Mullens","year":"2009","unstructured":"Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53(7):589\u201396.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"5166_CR5","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jacc","volume":"75","author":"GM Felker","year":"2020","unstructured":"Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM. Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(10):1178\u201395. https:\/\/doi.org\/10.1016\/j.jacc. 2019.12.059 PubMed PMID: 32164892.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"5166_CR6","doi-asserted-by":"publisher","first-page":"5924","DOI":"10.3390\/ijms25115924","volume":"25","author":"T Pais","year":"2024","unstructured":"Pais T, Jorge S, Lopes JA. Acute Kidney Injury in Sepsis. Int J Mol Sci. 2024;25(11):5924. https:\/\/doi.org\/10.3390\/ijms25115924.\u00a0PubMed PMID: 38892111; PubMed Central PMCID: PMC11172431.","journal-title":"Int J Mol Sci"},{"key":"5166_CR7","doi-asserted-by":"publisher","first-page":"F871","DOI":"10.1152\/ajprenal.00333.2004","volume":"288","author":"MS Goligorsky","year":"2005","unstructured":"Goligorsky MS. Endothelial cell dysfunction: can\u00b4t live with it, how to live without it. Am J Physiol Ren Physiol. 2005;288:F871\u2013880. https:\/\/doi.org\/10.1152\/ajprenal.00333.2004.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"6 Pt 2","key":"5166_CR8","first-page":"F769","volume":"260","author":"BA Molitoris","year":"1991","unstructured":"Molitoris BA. Ischemia-induced loss of epithelial polarity: potential role of the actin cytoskeleton. Am J Physiol. 1991;260(6 Pt 2):F769\u2013778. PubMed PMID: 2058700.","journal-title":"Am J Physiol"},{"key":"5166_CR9","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1681\/ASN.2006010017","volume":"17","author":"P Devarajan","year":"2006","unstructured":"Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol JASN. 2006;17:1503\u201320. https:\/\/doi.org\/10.1681\/ASN.2006010017.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"1","key":"5166_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1067\/mlc.2003.7","volume":"141","author":"A Kribben","year":"2003","unstructured":"Kribben A, Feldkamp T, Horbelt M, Lange B, Pietruck F, Herget-Rosenthal S, et al. ATP protects, by way of receptor-mediated mechanisms, against hypoxia-induced injury in renal proximal tubules. J Lab Clin Med. 2003;141(1):67\u201373. https:\/\/doi.org\/10.1067\/mlc.2003.7. PubMed PMID: 12518170.","journal-title":"J Lab Clin Med"},{"key":"5166_CR11","doi-asserted-by":"publisher","unstructured":"Basile DP, Anderson MD, Sutton TA. Pathophysiology of acute kidney injury. Compr Physiol. 2012;2(2):1303\u201353. https:\/\/doi.org\/10.1002\/cphy.c110041.\u00a0PubMed PMID: 23798302; PubMed Central PMCID: PMC3919808.","DOI":"10.1002\/cphy.c110041"},{"issue":"2","key":"5166_CR12","doi-asserted-by":"publisher","first-page":"2403652","DOI":"10.1080\/0886022X","volume":"46","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wu W, Li Y, Peng Z. Exploring the role and therapeutic potential of lipid metabolism in acute kidney injury. Ren Fail. 2024;46(2):2403652. https:\/\/doi.org\/10.1080\/0886022X. 2024.2403652 PubMed PMID: 39319697; PubMed Central PMCID: PMC11425701.","journal-title":"Ren Fail"},{"key":"5166_CR13","unstructured":"PRISMA statement [Internet]. [cited 2026 Jun 23]. Available from: https:\/\/www.prisma-statement.org."},{"key":"5166_CR14","doi-asserted-by":"crossref","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. In: Nephron Clinical Practice. Basel: Karger; 2012.","DOI":"10.1159\/000339789"},{"key":"5166_CR15","doi-asserted-by":"publisher","unstructured":"Ostermann M, Zarbock A, Goldstein S, Kashani K, Macedo E, Murugan R, et al. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement. JAMA Netw Open. 2020;3(10):e2019209. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.19209. PubMed PMID: 33021646.","DOI":"10.1001\/jamanetworkopen.2020.19209"},{"issue":"1","key":"5166_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40635-019-0280-z","volume":"7","author":"M Ostermann","year":"2019","unstructured":"Ostermann M, Schneider A, Rimmele T, Bobek I, van Dam M, Darmon M, et al. Report of the first AKI Round Table meeting: an initiative of the ESICM AKI Section. Intensive Care Med Exp. 2019;7(1):69. https:\/\/doi.org\/10.1186\/s40635-019-0280-z. PubMed PMID: 31811522; PubMed Central PMCID: PMC6898702.","journal-title":"Intensive Care Med Exp"},{"issue":"1","key":"5166_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-021-00284","volume":"7","author":"JA Kellum","year":"2021","unstructured":"Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders HJ. Acute kidney injury. Nat Rev Dis Primer. 2021;7(1):52. https:\/\/doi.org\/10.1038\/s41572-021-00284. -z PubMed PMID: 34267223.","journal-title":"Nat Rev Dis Primer"},{"key":"5166_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2253-13-36","volume":"13","author":"M Heeg","year":"2013","unstructured":"Heeg M, Mertens A, Ellenberger D, M\u00fcller GA, patschan daniel. Prognosis of AKI in malignant diseases with and without sepsis. BMC Anesthesiol. 2013;13:36. https:\/\/doi.org\/10.1186\/1471-2253-13-36. PubMed Central PMCID: PMC4175479.","journal-title":"BMC Anesthesiol"},{"key":"5166_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrneph.2013.282","volume":"10","author":"O Rewa","year":"2014","unstructured":"Rewa O, Bagshaw SM. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol. 2014;10:193\u2013207. https:\/\/doi.org\/10.1038\/nrneph.2013.282.","journal-title":"Nat Rev Nephrol"},{"key":"5166_CR20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00134-017-4809","volume":"43","author":"LG Forni","year":"2017","unstructured":"Forni LG, Darmon M, Ostermann M, Oudemans-van Straaten HM, Pettila V, Prowle JR, et al. Renal recovery after acute kidney injury. Intensive Care Med. 2017;43:855\u201366. https:\/\/doi.org\/10.1007\/s00134-017-4809. x PubMed Central PMCID: PMC5487594.","journal-title":"Intensive Care Med"},{"issue":"1","key":"5166_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.semnephrol.2016.01","volume":"36","author":"SR Mulay","year":"2016","unstructured":"Mulay SR, Holderied A, Kumar SV, Anders HJ. Targeting Inflammation in So-Called Acute Kidney Injury. Semin Nephrol. 2016;36(1):17\u201330. https:\/\/doi.org\/10.1016\/j.semnephrol.2016.01. 006 PubMed PMID: 27085732.","journal-title":"Semin Nephrol"},{"key":"5166_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1146\/annurev-physiol-042222-024724","volume":"86","author":"M Chrysopoulou","year":"2024","unstructured":"Chrysopoulou M, Rinschen MM. Metabolic Rewiring and Communication: An Integrative View of Kidney Proximal Tubule Function. Annu Rev Physiol. 2024;86:405\u201327. https:\/\/doi.org\/10.1146\/annurev-physiol-042222-024724. PubMed PMID: 38012048.","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"5166_CR23","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/path.5605","volume":"253","author":"AM Scantlebery","year":"2021","unstructured":"Scantlebery AM, Tammaro A, Mills JD, Rampanelli E, Kors L, Teske GJ, et al. The dysregulation of metabolic pathways and induction of the pentose phosphate pathway in renal ischaemia-reperfusion injury. J Pathol. 2021;253(4):404\u201314. https:\/\/doi.org\/10.1002\/path.5605 . PubMed PMID: 33338266; PubMed Central PMCID: PMC7986929.","journal-title":"J Pathol"},{"issue":"3","key":"5166_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/path.5882","volume":"257","author":"L Mart\u00edn-Saiz","year":"2022","unstructured":"Mart\u00edn-Saiz L, Guerrero-Mauvecin J, Mart\u00edn-Sanchez D, Fresnedo O, G\u00f3mez MJ, Carrasco S, et al. Ferrostatin-1 modulates dysregulated kidney lipids in acute kidney injury. J Pathol. 2022;257(3):285\u201399. https:\/\/doi.org\/10.1002\/path.5882 . PubMed PMID: 35152438.","journal-title":"J Pathol"},{"issue":"10","key":"5166_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41581-023-00741","volume":"19","author":"A Mitrofanova","year":"2023","unstructured":"Mitrofanova A, Merscher S, Fornoni A. Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease. Nat Rev Nephrol. 2023;19(10):629\u201345. https:\/\/doi.org\/10.1038\/s41581-023-00741. -w PubMed PMID: 37500941.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"5166_CR26","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1080\/15548627.2020.1782034","volume":"17","author":"T Yamamoto","year":"2021","unstructured":"Yamamoto T, Takabatake Y, Minami S, Sakai S, Fujimura R, Takahashi A, et al. Eicosapentaenoic acid attenuates renal lipotoxicity by restoring autophagic flux. Autophagy. 2021;17(7):1700\u201313. https:\/\/doi.org\/10.1080\/15548627.2020.1782034 . PubMed PMID: 32546086; PubMed Central PMCID: PMC8354598.","journal-title":"Autophagy"},{"issue":"3","key":"5166_CR27","doi-asserted-by":"publisher","first-page":"151281","DOI":"10.1016\/j.semnephrol.2022.10","volume":"42","author":"RJ Nicholson","year":"2022","unstructured":"Nicholson RJ, Holland WL, Summers SA. Ceramides and Acute Kidney Injury. Semin Nephrol. 2022;42(3):151281. https:\/\/doi.org\/10.1016\/j.semnephrol.2022.10. .007 PubMed PMID: 36404212; PubMed Central PMCID: PMC9907354.","journal-title":"Semin Nephrol"},{"issue":"11","key":"5166_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/sj.ki.5002192","volume":"71","author":"CM Hao","year":"2007","unstructured":"Hao CM, Breyer MD. Physiologic and pathophysiologic roles of lipid mediators in the kidney. Kidney Int. 2007;71(11):1105\u201315. https:\/\/doi.org\/10.1038\/sj.ki.5002192 . PubMed PMID: 17361113.","journal-title":"Kidney Int"},{"issue":"16","key":"5166_CR29","doi-asserted-by":"publisher","first-page":"8969","DOI":"10.3390\/ijms22168969","volume":"22","author":"M Tahri-Joutey","year":"2021","unstructured":"Tahri-Joutey M, Andreoletti P, Surapureddi S, Nasser B, Cherkaoui-Malki M, Latruffe N. Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPAR\u03b1. Int J Mol Sci. 2021;22(16):8969. https:\/\/doi.org\/10.3390\/ijms22168969 . PubMed PMID: 34445672; PubMed Central PMCID: PMC8396561.","journal-title":"Int J Mol Sci"},{"key":"5166_CR30","doi-asserted-by":"publisher","first-page":"619730","DOI":"10.3389\/fphys.2020.619730","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, Liu Z, Shu S, Cai J, Tang C, Dong Z. AMPK\/mTOR Signaling in Autophagy Regulation During Cisplatin-Induced Acute Kidney Injury. Front Physiol. 2020;11:619730. https:\/\/doi.org\/10.3389\/fphys.2020.619730 . PubMed PMID: 33391038; PubMed Central PMCID: PMC7773913.","journal-title":"Front Physiol"},{"key":"5166_CR31","doi-asserted-by":"publisher","first-page":"102382","DOI":"10.1016\/j.redox.2022.102382","volume":"54","author":"DH Kim","year":"2022","unstructured":"Kim DH, Choi HI, Park JS, Kim CS, Bae EH, Ma SK, et al. Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes. Redox Biol. 2022;54:102382. https:\/\/doi.org\/10.1016\/j.redox.2022.102382 . PubMed PMID: 35767918; PubMed Central PMCID: PMC9241134.","journal-title":"Redox Biol"},{"issue":"5","key":"5166_CR32","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.kint.2022.01.029","volume":"101","author":"S Xu","year":"2022","unstructured":"Xu S, Jia P, Fang Y, Jin J, Sun Z, Zhou W, et al. Nuclear farnesoid X receptor attenuates acute kidney injury through fatty acid oxidation. Kidney Int. 2022;101(5):987\u20131002. https:\/\/doi.org\/10.1016\/j.kint.2022.01.029 . PubMed PMID: 35227690.","journal-title":"Kidney Int"},{"issue":"12","key":"5166_CR33","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1681\/ASN.2019020163","volume":"30","author":"T Chiba","year":"2019","unstructured":"Chiba T, Peasley KD, Cargill KR, Maringer KV, Bharathi SS, Mukherjee E, et al. Sirtuin 5 Regulates Proximal Tubule Fatty Acid Oxidation to Protect against AKI. J Am Soc Nephrol JASN. 2019;30(12):2384\u201398. https:\/\/doi.org\/10.1681\/ASN.2019020163 . PubMed PMID: 31575700; PubMed Central PMCID: PMC6900790.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"10","key":"5166_CR34","doi-asserted-by":"publisher","first-page":"11926","DOI":"10.1021\/acs.jmedchem.5c03440","volume":"69","author":"Y Jiang","year":"2026","unstructured":"Jiang Y, Yang L, Xiong R, Zhang H, Liu W, Lei M, et al. X-ray Crystallography-Guided Discovery of a Potent Dual-Pocket Competitive SIRT5 Inhibitor against Sepsis-Associated AKI. J Med Chem. 2026;69(10):11926\u201347. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c03440 . PubMed PMID: 42143779.","journal-title":"J Med Chem"},{"issue":"8","key":"5166_CR35","doi-asserted-by":"publisher","first-page":"781","DOI":"10.34067\/KID.0000772019","volume":"1","author":"T Imafuku","year":"2020","unstructured":"Imafuku T, Watanabe H, Satoh T, Matsuzaka T, Inazumi T, Kato H, et al. Advanced Oxidation Protein Products Contribute to Renal Tubulopathy via Perturbation of Renal Fatty Acids. Kidney360. 2020;1(8):781\u201396. https:\/\/doi.org\/10.34067\/KID.0000772019 . PubMed PMID: 35372949; PubMed Central PMCID: PMC8815742.","journal-title":"Kidney360"},{"issue":"9","key":"5166_CR36","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.1111\/jcmm.15148","volume":"24","author":"M Li","year":"2020","unstructured":"Li M, Li CM, Ye ZC, Huang J, Li Y, Lai W, et al. Sirt3 modulates fatty acid oxidation and attenuates cisplatin-induced AKI in mice. J Cell Mol Med. 2020;24(9):5109\u201321. https:\/\/doi.org\/10.1111\/jcmm.15148 . PubMed PMID: 32281286; PubMed Central PMCID: PMC7205836.","journal-title":"J Cell Mol Med"},{"key":"5166_CR37","doi-asserted-by":"publisher","first-page":"112089","DOI":"10.1016\/j.cbi.2026.112089","volume":"434","author":"Y Wang","year":"2026","unstructured":"Wang Y, Wang W, Sun J, Zhou S, Ni L, Dong M, et al. Exogenous pyruvate restores mitochondrial bioenergetics by synergizing with the AMPK-mTOR-SIRT3 pathway to alleviate sepsis-associated acute kidney injury. Chem Biol Interact. 2026;434:112089. https:\/\/doi.org\/10.1016\/j.cbi.2026.112089 . PubMed PMID: 42031090.","journal-title":"Chem Biol Interact"},{"key":"5166_CR38","doi-asserted-by":"publisher","first-page":"107760","DOI":"10.1016\/j.intimp.2021.107760","volume":"96","author":"L Li","year":"2021","unstructured":"Li L, Tao S, Guo F, Liu J, Huang R, Tan Z, et al. Genetic and pharmacological inhibition of fatty acid-binding protein 4 alleviated inflammation and early fibrosis after toxin induced kidney injury. Int Immunopharmacol. 2021;96:107760. https:\/\/doi.org\/10.1016\/j.intimp.2021.107760 . PubMed PMID: 33991998.","journal-title":"Int Immunopharmacol"},{"key":"5166_CR39","doi-asserted-by":"publisher","first-page":"179061","DOI":"10.1016\/j.ejphar.2026.179061","volume":"1030","author":"J Ye","year":"2026","unstructured":"Ye J, Wang Y, Xie L, He S, Shi X, Gao Y, et al. Pharmacological inhibition of fatty acid-binding protein 4 alleviates sepsis-associated acute kidney injury in mice via suppressing ferroptosis. Eur J Pharmacol. 2026;1030:179061. https:\/\/doi.org\/10.1016\/j.ejphar.2026.179061 . PubMed PMID: 42219054.","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"5166_CR40","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.kint.2021.08.031","volume":"100","author":"SE Piret","year":"2021","unstructured":"Piret SE, Attallah AA, Gu X, Guo Y, Gujarati NA, Henein J, et al. Loss of proximal tubular transcription factor Kr\u00fcppel-like factor 15 exacerbates kidney injury through loss of fatty acid oxidation. Kidney Int. 2021;100(6):1250\u201367. .031 PubMed PMID: 34634362; PubMed Central PMCID: PMC8608748.","journal-title":"Kidney Int"},{"key":"5166_CR41","doi-asserted-by":"publisher","first-page":"100300","DOI":"10.1016\/j.crtox.2026.100300","volume":"10","author":"L Chen","year":"2026","unstructured":"Chen L, Xie S, Yang H, Liu X, Yang S, Wang D. Loss of KLF15 expression characterizes proximal tubule injury in cisplatin-induced acute kidney injury: A multi-omics study. Curr Res Toxicol. 2026;10:100300. https:\/\/doi.org\/10.1016\/j.crtox.2026.100300 . PubMed PMID: 42238184; PubMed Central PMCID: PMC13226791.","journal-title":"Curr Res Toxicol"},{"issue":"10","key":"5166_CR42","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.7150\/thno.56082","volume":"11","author":"W Xiong","year":"2021","unstructured":"Xiong W, Xiong Z, Song A, Lei C, Ye C, Zhang C. Relieving lipid accumulation through UCP1 suppresses the progression of acute kidney injury by promoting the AMPK\/ULK1\/autophagy pathway. Theranostics. 2021;11(10):4637\u201354. https:\/\/doi.org\/10.7150\/thno.56082 . PubMed PMID: 33754018; PubMed Central PMCID: PMC7978316.","journal-title":"Theranostics"},{"issue":"1","key":"5166_CR43","doi-asserted-by":"publisher","first-page":"2508908","DOI":"10.1080\/0886022X.2025.2508908","volume":"47","author":"N Bao","year":"2025","unstructured":"Bao N, Gu MJ, Huang QY, Sun HJ, Zhu XX, Gu X, et al. Baicalin alleviates sepsis-associated acute kidney injury through activation of the PPAR-\u03b3\/UCP1 signaling pathway. Ren Fail. 2025;47(1):2508908. PubMed PMID: 40509797; PubMed Central PMCID: PMC12168399.","journal-title":"Ren Fail"},{"issue":"4","key":"5166_CR44","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41419-022-04794-w","volume":"13","author":"B Wang","year":"2022","unstructured":"Wang B, Xu J, Ren Q, Cheng L, Guo F, Liang Y, et al. Fatty acid-binding protein 4 is a therapeutic target for septic acute kidney injury by regulating inflammatory response and cell apoptosis. Cell Death Dis. 2022;13(4):333. https:\/\/doi.org\/10.1038\/s41419-022-04794-w . PubMed PMID: 35410456; PubMed Central PMCID: PMC9001746.","journal-title":"Cell Death Dis"},{"key":"5166_CR45","doi-asserted-by":"publisher","DOI":"10.1101\/2024.10.22.619640","author":"T Chiba","year":"2024","unstructured":"Chiba T, Oda A, Zhang Y, Bons J, Bharathi SS, Pfister KE, et al. Loss of long-chain acyl-CoA dehydrogenase protects against acute kidney injury. bioRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.10.22.619640 . PubMed PMID: 39484612; PubMed Central PMCID: PMC11526992. 2024.10.22.619640.","journal-title":"bioRxiv"},{"issue":"5","key":"5166_CR46","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.4049\/jimmunol.0802064","volume":"182","author":"IR Hassan","year":"2009","unstructured":"Hassan IR, Gronert K. Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. J Immunol Baltim Md 1950. 2009;182(5):3223\u201332. https:\/\/doi.org\/10.4049\/jimmunol.0802064 . PubMed PMID: 19234220.","journal-title":"J Immunol Baltim Md 1950"},{"issue":"47","key":"5166_CR47","doi-asserted-by":"publisher","first-page":"12608","DOI":"10.1073\/pnas.1705615114","volume":"114","author":"BQ Deng","year":"2017","unstructured":"Deng BQ, Luo Y, Kang X, Li CB, Morisseau C, Yang J, et al. Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3\u03b2 signaling. Proc Natl Acad Sci U S A. 2017;114(47):12608\u201313. https:\/\/doi.org\/10.1073\/pnas.1705615114 . PubMed PMID: 29109264; PubMed Central PMCID: PMC5703276.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"5166_CR48","doi-asserted-by":"publisher","first-page":"e505","DOI":"10.1177\/1098612X221136815","volume":"24","author":"S Kobayashi","year":"2022","unstructured":"Kobayashi S, Kawarasaki M, Aono A, Cho J, Hashimoto T, Sato R. Renoprotective effects of docosahexaenoic acid in cats with early chronic kidney disease due to polycystic kidney disease: a pilot study. J Feline Med Surg. 2022;24(12):e505\u201312. https:\/\/doi.org\/10.1177\/1098612X221136815 . PubMed PMID: 36383208; PubMed Central PMCID: PMC10812349.","journal-title":"J Feline Med Surg"},{"key":"5166_CR49","doi-asserted-by":"publisher","first-page":"1365802","DOI":"10.3389\/fphar.2024.1365802","volume":"15","author":"XJ Li","year":"2024","unstructured":"Li XJ, Suo P, Wang YN, Zou L, Nie XL, Zhao YY, et al. Arachidonic acid metabolism as a therapeutic target in AKI-to-CKD transition. Front Pharmacol. 2024;15:1365802. https:\/\/doi.org\/10.3389\/fphar.2024.1365802 . PubMed PMID: 38523633; PubMed Central PMCID: PMC10957658.","journal-title":"Front Pharmacol"},{"key":"5166_CR50","doi-asserted-by":"publisher","first-page":"153818","DOI":"10.1016\/j.phymed.2021.153818","volume":"94","author":"B Zhang","year":"2022","unstructured":"Zhang B, Zeng M, Wang Y, Li M, Wu Y, Xu R, et al. Oleic acid alleviates LPS-induced acute kidney injury by restraining inflammation and oxidative stress via the Ras\/MAPKs\/PPAR-\u03b3 signaling pathway. Phytomedicine Int J Phytother Phytopharm. 2022;94:153818. https:\/\/doi.org\/10.1016\/j.phymed.2021.153818 . PubMed PMID: 34798521.","journal-title":"Phytomedicine Int J Phytother Phytopharm"},{"issue":"11","key":"5166_CR51","doi-asserted-by":"publisher","first-page":"6103","DOI":"10.1039\/d1fo04178a","volume":"13","author":"HH Shi","year":"2022","unstructured":"Shi HH, Chen LP, Wang CC, Zhao YC, Wang YM, Xue CH, et al. Docosahexaenoic acid-acylated curcumin diester alleviates cisplatin-induced acute kidney injury by regulating the effect of gut microbiota on the lipopolysaccharide- and trimethylamine-N-oxide-mediated PI3K\/Akt\/NF-\u03baB signaling pathway in mice. Food Funct. 2022;13(11):6103\u201317. https:\/\/doi.org\/10.1039\/d1fo04178a . PubMed PMID: 35575345.","journal-title":"Food Funct"},{"key":"5166_CR52","doi-asserted-by":"publisher","first-page":"109418","DOI":"10.1016\/j.jnutbio.2023.109418","volume":"120","author":"K Shan","year":"2023","unstructured":"Shan K, Li J, Yang Q, Chen K, Zhou S, Jia L, et al. Dietary docosahexaenoic acid plays an opposed role in ferroptotic and non-ferroptotic acute kidney injury. J Nutr Biochem. 2023;120:109418. https:\/\/doi.org\/10.1016\/j.jnutbio.2023.109418 . PubMed PMID: 37490984.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"5166_CR53","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/metabo12010058","volume":"12","author":"X Zhang","year":"2022","unstructured":"Zhang X, Li X. Abnormal Iron and Lipid Metabolism Mediated Ferroptosis in Kidney Diseases and Its Therapeutic Potential. Metabolites. 2022;12(1):58. https:\/\/doi.org\/10.3390\/metabo12010058.\u00a0PubMed PMID: 35050181; PubMed Central PMCID: PMC8779729.","journal-title":"Metabolites"},{"key":"5166_CR54","doi-asserted-by":"publisher","first-page":"116094","DOI":"10.1016\/j.biopha.2023.116094","volume":"171","author":"F Comella","year":"2024","unstructured":"Comella F, Lama A, Pirozzi C, Annunziata C, Piegari G, Sodano F, et al. Oleoylethanolamide attenuates acute-to-chronic kidney injury: in vivo and in vitro evidence of PPAR-\u03b1 involvement. Biomed Pharmacother Biomedecine Pharmacother. 2024;171:116094. https:\/\/doi.org\/10.1016\/j.biopha.2023.116094 . PubMed PMID: 38183745.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"issue":"2","key":"5166_CR55","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1681\/ASN.0000000000000266","volume":"35","author":"AC Silva Barbosa","year":"2024","unstructured":"Silva Barbosa AC, Pfister KE, Chiba T, Bons J, Rose JP, Burton JB, et al. Dicarboxylic Acid Dietary Supplementation Protects against AKI. J Am Soc Nephrol JASN. 2024;35(2):135\u201348. https:\/\/doi.org\/10.1681\/ASN.0000000000000266 . PubMed PMID: 38044490; PubMed Central PMCID: PMC10843194.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"10","key":"5166_CR56","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.34067\/KID.0000000574","volume":"5","author":"K Tokumaru","year":"2024","unstructured":"Tokumaru K, Imafuku T, Satoh T, Inazumi T, Hirashima S, Nishinoiri A, et al. Omega 3 Fatty Acids Attenuate the Acute Kidney Injury to CKD Transition and Renal Fibrosis: Identification of Antifibrotic Metabolites. Kidney360. 2024;5(10):1422\u201334. 0000000574 PubMed PMID: 39259608; PubMed Central PMCID: PMC11556936.","journal-title":"Kidney360"},{"key":"5166_CR57","doi-asserted-by":"publisher","unstructured":"Erfurt S, Gruzla J, Weylandt KH, Ritter O, Hoffmeister M, Patschan D. Lipids and lipid metabolites in the diagnosis, risk prediction and treatment of chronic kidney disease and acute kidney injury. Kidney Blood Press Res. 2026;1\u201330. https:\/\/doi.org\/10.1159\/000552568.\u00a0PMID: 42176287.","DOI":"10.1159\/000552568"},{"issue":"10","key":"5166_CR58","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.2215\/CJN.10441013","volume":"9","author":"EK Hoogeveen","year":"2014","unstructured":"Hoogeveen EK, Geleijnse JM, Kromhout D, Stijnen T, Gemen EF, Kusters R, et al. Effect of Omega-3 Fatty Acids on Kidney Function after Myocardial Infarction: The Alpha Omega Trial. Clin J Am Soc Nephrol. 2014;9(10):1676. https:\/\/doi.org\/10.2215\/CJN.10441013.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"5166_CR59","doi-asserted-by":"publisher","first-page":"328","DOI":"10.4103\/1319-2442.335443","volume":"32","author":"FA Alrowaie","year":"2021","unstructured":"Alrowaie FA, Almatham KI, Alsamadi F, Bashir MS, Munshi HH. Could Omega 3 Fatty Acids Reduce the Risk of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography? A Randomized Controlled Trial. Saudi J Kidney Dis Transpl. 2021;32(2):328. https:\/\/doi.org\/10.4103\/1319-2442.335443.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"5166_CR60","doi-asserted-by":"publisher","unstructured":"Yin H, Zhu GQ, Wang HZ, Yang BB, Wang ZX, Xie H. Organoids: generation strategies, applications, and future challenges. Stem Cell Res Ther. 2026 May;22. https:\/\/doi.org\/10.1186\/s13287-026-05045-x. PubMed PMID: 42174698.","DOI":"10.1186\/s13287-026-05045-x"},{"issue":"5","key":"5166_CR61","doi-asserted-by":"publisher","first-page":"dmm052716","DOI":"10.1242\/dmm.052716","volume":"19","author":"H Elsaid","year":"2026","unstructured":"Elsaid H, Furriol J, Eikrem \u00d8, T\u00f8ndel C, Svarstad E. Modeling Fabry nephropathy: insights from experimental systems towards precision nephrology. Dis Model Mech. 2026;19(5):dmm052716. https:\/\/doi.org\/10.1242\/dmm.052716 . PubMed PMID: 42212514.","journal-title":"Dis Model Mech"},{"key":"5166_CR62","doi-asserted-by":"publisher","unstructured":"Guo B, Zhang J, Fang X, Liu Y, Deng Y, Xue Y, et al. Bridging kidney organoid innovation and regenerative medicine: current advances and future directions. Cell Prolif. 2026:e70228. https:\/\/doi.org\/10.1111\/cpr.70228. PubMed PMID: 42138431.","DOI":"10.1111\/cpr.70228"},{"key":"5166_CR63","doi-asserted-by":"publisher","unstructured":"Lopes FM, Bantounas I, Sarov A, Woolf AS, Kimber SJ. Human pluripotent stem cell-derived macrophages modify development of human kidney organoids: a preliminary study. Nephron. 2026:1\u201327. https:\/\/doi.org\/10.1159\/000552689.\u00a0PMID: 42207751.","DOI":"10.1159\/000552689"},{"key":"5166_CR64","doi-asserted-by":"publisher","unstructured":"van den Berge BT, Smeets B, Schreuder MF, Jansen J. Human kidney organoids to uncover preterm birth-associated low nephron endowment. Nephron. 2026:1\u201324. https:\/\/doi.org\/10.1159\/000552561.\u00a0PMID: 42149792.","DOI":"10.1159\/000552561"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05166-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05166-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05166-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T20:03:28Z","timestamp":1784059408000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05166-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5166"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05166-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors agreed to submit the final version of the manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"423"}}